Genetic Signatures Ltd (GSS)

Currency in AUD
0.320
-0.005(-1.54%)
Closed·
GSS Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Trading near 52-week Low
GSS is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.3200.325
52 wk Range
0.3200.755
Key Statistics
Bid/Ask
0.315 / 0.335
Prev. Close
0.325
Open
0.325
Day's Range
0.32-0.325
52 wk Range
0.32-0.755
Volume
214.31K
Average Volume (3m)
121.34K
1-Year Change
-56.67%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
GSS Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
0.685
Upside
+114.06%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Genetic Signatures Ltd Company Profile

Genetic Signatures Limited operates as a molecular diagnostic company in Australia, the Asia Pacific, Europe, the Middle East, Asia, and the Americas. The company offers enteric bacteria, Enteroaggregative E.coli aggR and aaiC, enteric viral, enteric protozoan, enteric protozoan extended, enteric microsporidia, respiratory pathogen, SARS-CoV-2, SARS-CoV-2 respiratory plus, coronavirus, atypical respiratory, pertussis and PCP, parainfluenza 4, STI genital pathogen, extended spectrum beta-lactamase and carbapenemase producing organisms, viral meningitis, flavivirus dengue alphavirus, flavivirus reflex, dengue typing, and alphavirus reflex Detection kits under the EasyScreen name. Genetic Signatures Limited was incorporated in 2001 and is headquartered in Newtown, Australia.

Compare GSS to Peers and Sector

Metrics to compare
GSS
Peers
Sector
Relationship
P/E Ratio
−3.3x−0.8x−0.5x
PEG Ratio
−0.280.000.00
Price/Book
1.4x1.7x2.6x
Price / LTM Sales
4.0x3.5x3.3x
Upside (Analyst Target)
110.8%120.5%43.5%
Fair Value Upside
Unlock8.2%6.9%Unlock

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 0.685
(+114.06% Upside)

Earnings

Latest Release
May 28, 2025
EPS / Forecast
-- / --
Revenue / Forecast
2.90M / --
EPS Revisions
Last 90 days

GSS Income Statement

FAQ

What Stock Exchange Does Genetic Signatures Ltd Trade On?

Genetic Signatures Ltd is listed and trades on the Sydney Stock Exchange stock exchange.

What Is the Stock Symbol for Genetic Signatures Ltd?

The stock symbol for Genetic Signatures Ltd is "GSS."

What Is the Genetic Signatures Ltd Market Cap?

As of today, Genetic Signatures Ltd market cap is 72.69M.

What Is Genetic Signatures Ltd's Earnings Per Share (TTM)?

The Genetic Signatures Ltd EPS (TTM) is -0.11.

When Is the Next Genetic Signatures Ltd Earnings Date?

Genetic Signatures Ltd will release its next earnings report on 27 Aug 2025.

From a Technical Analysis Perspective, Is GSS a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Genetic Signatures Ltd Stock Split?

Genetic Signatures Ltd has split 0 times.

How Many Employees Does Genetic Signatures Ltd Have?

Genetic Signatures Ltd has 0 employees.

What is the current trading status of Genetic Signatures Ltd (GSS)?

As of 07 Aug 2025, Genetic Signatures Ltd (GSS) is trading at a price of 0.32, with a previous close of 0.33. The stock has fluctuated within a day range of 0.32 to 0.33, while its 52-week range spans from 0.32 to 0.76.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.